PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rescuing the Golgi puts brakes on Alzheimer's progression

New findings say attending to the Golgi slows AD protein accumulation significantly.

2014-12-05
(Press-News.org) Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang Wang, Gunjan Joshi, and colleagues at the University of Michigan, Ann Arbor, as they set out to uncover the mechanism damaging the Golgi, using a transgenic mouse and tissue culture models of AD to look at what was going on.

The unsurprising part of the answer was that rising levels of Aβ do lead directly to Golgi fragmentation by activating a cell cycle kinase, cdk5. The surprising part of the answer was that Golgi function can be rescued by blocking cdk5 or shielding its downstream target protein in the Golgi, GRASP65. The even more surprising answer was that rescuing the Golgi reduced Aβ accumulation significantly, apparently by re-opening a normal protein degradation pathway for the amyloid precursor protein (APP). To Wang et al, this suggested an entirely new line of attack for drugs hoping to slow AD progression.

Speaking at the ASCB/IFCB Meeting in Philadelphia, the researchers now say that Golgi fragmentation is in itself a major--and until now an unrecognized--mechanism through which Aβ extends its toxic effects. They believe that as Aβ accumulation rises, damage to the Golgi increases, which in turn accelerates APP trafficking, which in turn increases Aβ production. This is a classic "deleterious feedback circuit," they say. By blocking cdk5 or its downstream target, that circuit can be broken or greatly slowed. "Our study provides a molecular mechanism for Golgi fragmentation and its effects on APP trafficking and processing in AD, suggesting Golgi as a potential drug target for AD treatment," the Michigan researchers report.

INFORMATION:

Golgi defects in Alzheimer's disease G. Joshi1, Y. Chi1, Z. Huang1, Y. Wang1; 1Dept. of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI

Contact: Yanzhuang Wang, yzwang@umich.edu

Author presents at ASCB: Poster Session: Establishing and Maintaining Organelle Structure

Tuesday, December 9
Board 626
Presentation 2103
Time: 1:30 to 3:00 pm

Media Contacts:
John Fleischman
jfleischman@ascb.org
513.706-0212 (mobile)

Carol Blymire
carol@carolblymire.com
301.332.8090 (mobile)



ELSE PRESS RELEASES FROM THIS DATE:

Gravity: It's the law, even for cells

Gravity: Its the law, even for cells
2014-12-05
VIDEO: Nucleoli (green), small liquid-like nuclear bodies, are kept small and afloat by a fine actin mesh. When the mesh breaks, the nucleoli quickly being to fall and coalesce into larger... Click here for more information. Everybody knows that cells are microscopic, but why? Why aren't cells bigger? The average animal cell is 10 microns across and the traditional explanation has been cells are the perfect size because if they were any bigger it would be difficult to get enough ...

Light switchable proteins and superresolution reveal moving protein complexes

2014-12-05
Cells are restless. They move during embryogenesis, tissue repair, regeneration, chemotaxis. Even in disease, tumor metastasis, cells get around. To do this, they have to keep reorganizing their cytoskeleton, removing pieces from one end of a microtubule and adding them to the front, like a railroad with a limited supply of tracks. The EB family of proteins helps regulate this process and can act as a scaffold for other proteins involved in pushing the microtubule chain forward. Still, how these EB proteins function in space and time has remained a mystery. Now Peng ...

The antioxidant capacity of orange juice is multiplied tenfold

The antioxidant capacity of orange juice is multiplied tenfold
2014-12-05
The antioxidant activity of citrus juices and other foods is undervalued. A new technique developed by researchers from the University of Granada for measuring this property generates values that are ten times higher than those indicated by current analysis methods. The results suggest that tables on the antioxidant capacities of food products that dieticians and health authorities use must be revised. Orange juice and juices from other citrus fruits are considered healthy due to their high content of antioxidants, which help to reduce harmful free radicals in our body, ...

Penicillin tactics revealed

2014-12-05
Penicillin, the wonder drug discovered in 1928, works in ways that are still mysterious almost a century later. One of the oldest and most widely used antibiotics, it attacks enzymes that build the bacterial cell wall, a mesh that surrounds the bacterial membrane and gives the cells their integrity and shape. Once that wall is breached, bacteria die -- allowing us to recover from infection. That would be the end of the story, if resistance to penicillin and other antibiotics hadn't emerged over recent decades as a serious threat to human health. While scientists continue ...

Stick out your tongue

2014-12-05
Physicians often ask their patients to "Please stick out your tongue". The tongue can betray signs of illness, which combined with other symptoms such as a cough, fever, presence of jaundice, headache or bowel habits, can help the physician offer a diagnosis. For people in remote areas who do not have ready access to a physician, a new diagnostic system is reported in the International Journal of Biomedical Engineering and Technology that works to combine the soft inputs of described symptoms with a digital analysis of an image of the patient's tongue. Karthik Ramamurthy ...

IRCM researchers identify a protein that controls the 'guardian of the genome'

2014-12-05
Montréal, December 5, 2014 - A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome". The researchers study the development of T cells and B cells, which are lymphocytes (or immune cells) that play a central role in protecting our ...

Drugs in the environment affect plant growth

2014-12-05
The drugs we release into the environment are likely to have a significant impact on plant growth, a new study has revelealed. By assessing the impacts of a range of non-steroidal anti-inflammatory drugs, researchers at the University of Exeter Medical School and Plymouth University have shown that the growth of edible crops can be affected by these chemicals - even at the very low concentrations found in the environment. Published in the Journal of Ecotoxicology and Environmental Safety, the research focused its analysis on lettuce and radish plants and tested the ...

Salience network is linked to brain disorders

2014-12-05
CORAL GABLES, Fla (December 4, 2014) -- How does the brain determine what matters? According to a new scientific article, a brain structure called the insula is essential for selecting things out of the environment that are "salient" for an individual, and dysfunction of this system is linked to brain disorders such as autism, psychosis and dementia. In psychology and neuroscience, the term "salient" is used to describe a thing, person, place or event that stands out, or that is set apart from others. The current article, published online by Nature Reviews Neuroscience ...

Apixaban in DVT and pulmonary embolism: Patients with high BMI benefit considerably

2014-12-05
Apixaban (trade name Eliquis) has been approved since July 2014 for acute treatment of adults with deep vein thrombosis or pulmonary embolism. In addition, the drug can be used for low-dose long-term treatment to prevent recurrent thrombosis or pulmonary embolism. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether in these cases the drug offers patients an added benefit over the appropriate comparator therapies. According to the findings, considerable added benefit of apixaban is proven for the initial treatment ...

Social networking during a campus emergency

2014-12-05
Emergencies at educational establishments are on the increase in recent years and campus officials are beginning to recognize that better communications with their students are now needed. Writing in the International Journal of Business Information Systems, US researchers describe how social networking sites might be exploited when an emergency situation arises to help safeguard students as well as keeping those not directly involved in the situation informed of events. The same insights might be applied in the business environment too. Wencui Han of the Department of ...

LAST 30 PRESS RELEASES:

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing

New book Terraglossia reclaims language, Country and culture

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

[Press-News.org] Rescuing the Golgi puts brakes on Alzheimer's progression
New findings say attending to the Golgi slows AD protein accumulation significantly.